$21.11 +0.05 (0.21%)

Surgery Partners, Inc. Common Stock (SGRY)

Surgery Partners, Inc. (SGRY) is a healthcare company that provides outpatient surgical services through a network of surgical facilities across the United States. The company focuses on delivering specialized procedures in areas such as outpatient surgery, endoscopy, pain management, and other ambulatory care services, aiming to improve patient outcomes and streamline healthcare delivery.

🚫 Surgery Partners, Inc. Common Stock does not pay dividends

Company News

Surgery Partners (SGRY) Q2 Revenue Up 8%
The Motley Fool • Jesterai • August 6, 2025

Surgery Partners reported Q2 2025 revenue of $826.2 million, an 8.4% year-over-year increase, with mixed financial results. The company saw strong case volume growth and reaffirmed full-year guidance, despite challenges with net losses and higher network growth costs.

Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Details
GlobeNewswire Inc. • Surgery Partners Investor Relations • July 18, 2025

Surgery Partners will release its second quarter 2025 financial results on August 5, 2025, with a conference call at 8:30 a.m. Eastern Time, providing investors an opportunity to hear about the company's performance.

Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital
Benzinga • Globe Newswire • January 28, 2025

Surgery Partners, Inc. has received a non-binding acquisition proposal from Bain Capital to acquire all outstanding shares not already owned by Bain Capital for $25.75 per share. A special committee of independent directors will consider the proposal with the assistance of advisors.

After-hours movers: Netflix, Intuitive Surgical, and more By Investing.com - Investing.com Canada
Investing.com • Louis Juricic • July 18, 2024

Netflix reported mixed Q2 results, with better-than-expected earnings but weaker guidance. Intuitive Surgical saw strong Q2 results, with a 17% increase in procedures. Plug Power announced a $200 million stock offering, while Surgery Partners is exploring strategic options including a potential sale.

Teladoc (TDOC) Soars 6.7%: Is Further Upside Left in the Stock?
Zacks Investment Research • Zacks Equity Research • June 25, 2024

Teladoc (TDOC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Related Companies